Clinical trial
Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II
NCT00247169 · Medical University of Vienna, Other · Completed
Key facts
| NCT number | NCT00247169 |
|---|---|
| Title | Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II |
| Official title | Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II: A Phase II Trial |
| Lead sponsor | Medical University of Vienna, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cervical Intraepithelial Neoplasia |
| Intervention type | Drug |
| Interventions | progesterone |
| Enrollment | 40 |
| Start date | Aug 1, 2004 |
| Primary completion | Apr 1, 2009 |
| Completion | Apr 1, 2010 |
| First posted | Nov 1, 2005 |
| Last update posted | Mar 9, 2012 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: